Green Cross Cell Corp. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
29,866
43,804
29,750
11,909
19,537
Cost of Goods Sold (COGS) incl. D&A
27,511
36,364
21,828
6,735
9,085
Gross Income
2,356
7,440
7,923
5,174
10,452
SG&A Expense
6,939
6,331
6,020
3,480
7,242
EBIT
4,606
1,092
1,876
-
3,189
Unusual Expense
3,880
3,229
1,163
646
226
Non Operating Income/Expense
396
373
2,102
187
311
Interest Expense
551
426
282
-
180
Pretax Income
7,694
1,727
2,834
1,361
3,200
Income Tax
252
524
139
28
1
Equity in Affiliates
233
-
300
-
-
Consolidated Net Income
7,675
2,251
2,994
1,333
3,201
Net Income
7,662
2,251
2,994
1,333
3,201
Net Income After Extraordinaries
7,662
2,251
2,994
2,760
5,685
Net Income Available to Common
7,662
2,251
2,994
93
3,076
EPS (Basic)
172.43
193.00
256.00
8.00
61.00
Basic Shares Outstanding
44
12
12
12
12
EPS (Diluted)
172.43
193.16
256.22
7.96
61.43
Diluted Shares Outstanding
44
12
12
12
12
EBITDA
3,552
1,931
2,715
2,170
4,150
Other Operating Expense
23
18
27
15
21
Non-Operating Interest Income
946
464
301
141
107
Minority Interest Expense
13
-
-
-
-

About Green Cross Cell

View Profile
Address
6/F, SJ Technoville
Seoul SL 08511
Korea, Republic Of
Employees -
Website http://www.greencrosscell.com
Updated 09/14/2018
Green Cross Cell Corp. engages in the provision of anti-cancer immunotherapy. It operates through following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation and KGMP Service. The company was founded on September 17, 1992 and is headquartered in Seoul, South Korea.